{"id":"https://openalex.org/W4281663502","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.tps617","title":"A single-arm, phase 2 study of perioperative ipilimumab, nivolumab, and cryoablation in women with hormone receptor-negative, HER2-negative, early-stage/resectable breast cancer.","display_name":"A single-arm, phase 2 study of perioperative ipilimumab, nivolumab, and cryoablation in women with hormone receptor-negative, HER2-negative, early-stage/resectable breast cancer.","publication_year":2022,"publication_date":"2022-06-01","ids":{"openalex":"https://openalex.org/W4281663502","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.tps617"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2022.40.16_suppl.tps617","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.tps617","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.tps617","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007002927","display_name":"Heather L. McArthur","orcid":"https://orcid.org/0000-0002-0201-3871","observed_orcids":["https://orcid.org/0000-0002-0201-3871"]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heather L. McArthur","raw_affiliation_strings":["University of Texas Southwestern Medical Center, Dallas, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Southwestern Medical Center, Dallas, TX;","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009038938","display_name":"Elizabeth Anne Comen","orcid":"https://orcid.org/0000-0002-9179-0399","observed_orcids":["https://orcid.org/0000-0002-9179-0399"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth Anne Comen","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY;","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061839424","display_name":"Yolanda C. D. Bryce","orcid":"https://orcid.org/0000-0002-8956-3947","observed_orcids":["https://orcid.org/0000-0002-8956-3947"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yolanda Bryce","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY;","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029855909","display_name":"Stephen Barnett Solomon","orcid":"https://orcid.org/0000-0001-5108-1021","observed_orcids":["https://orcid.org/0000-0001-5108-1021"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen Barnett Solomon","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY;","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042082543","display_name":"Jorge Henrique Santos Leal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jorge Henrique S. Leal","raw_affiliation_strings":["CLION-CAM Group, Salvador, Brazil;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CLION-CAM Group, Salvador, Brazil;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050826635","display_name":"Christina DiLauro Abaya","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christina DiLauro Abaya","raw_affiliation_strings":["UT Southwestern, Dallas, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UT Southwestern, Dallas, TX;","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032831211","display_name":"Cristal Martinez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cristal Martinez","raw_affiliation_strings":["Cedars-Sinai Medical Center, West Hollywood, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cedars-Sinai Medical Center, West Hollywood, CA;","institution_ids":["https://openalex.org/I1282927834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039500399","display_name":"Reva Kakkar Basho","orcid":"https://orcid.org/0000-0002-4132-7523","observed_orcids":["https://orcid.org/0000-0002-4132-7523"]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Reva K Basho","raw_affiliation_strings":["Cedars-Sinai Medical Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cedars-Sinai Medical Center, Houston, TX;","institution_ids":["https://openalex.org/I1282927834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050447425","display_name":"Dorothy J. Park","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100502","display_name":"Beverly Hills Cancer Center","ror":"https://ror.org/00j1j3213","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210100502"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dorothy J. Park","raw_affiliation_strings":["Twr Hem Onc Med Grp, Beverly Hills, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Twr Hem Onc Med Grp, Beverly Hills, CA;","institution_ids":["https://openalex.org/I4210100502"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109576591","display_name":"Philomena F. McAndrew","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100502","display_name":"Beverly Hills Cancer Center","ror":"https://ror.org/00j1j3213","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210100502"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Philomena McAndrew","raw_affiliation_strings":["Twr Hem Onc Medcl Grp, Beverly Hills, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Twr Hem Onc Medcl Grp, Beverly Hills, CA;","institution_ids":["https://openalex.org/I4210100502"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044243878","display_name":"Brigid Larkin","orcid":"https://orcid.org/0009-0005-4619-2495","observed_orcids":["https://orcid.org/0009-0005-4619-2495"]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brigid Larkin","raw_affiliation_strings":["Cedars-Sinai Medical Center Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cedars-Sinai Medical Center Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA;","institution_ids":["https://openalex.org/I1282927834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038168352","display_name":"William Mills","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William Mills","raw_affiliation_strings":["Cedars-Sinai Medical Center, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cedars-Sinai Medical Center, Los Angeles, CA;","institution_ids":["https://openalex.org/I1282927834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017531113","display_name":"David B. Page","orcid":"https://orcid.org/0000-0001-9264-4628","observed_orcids":["https://orcid.org/0000-0001-9264-4628"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David B. Page","raw_affiliation_strings":["Earle A. Chiles Research Institute at the Robert W. Franz Cancer Center, Portland, OR;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Earle A. Chiles Research Institute at the Robert W. Franz Cancer Center, Portland, OR;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020313792","display_name":"Staci L. Mellinger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801670537","display_name":"Providence Portland Medical Center","ror":"https://ror.org/015tmw922","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801670537","https://openalex.org/I4210160466","https://openalex.org/I94396219"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Staci L. Mellinger","raw_affiliation_strings":["Providence Cancer Center, Portland, OR;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Providence Cancer Center, Portland, OR;","institution_ids":["https://openalex.org/I2801670537"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047486711","display_name":"Nicole Fredrich","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801670537","display_name":"Providence Portland Medical Center","ror":"https://ror.org/015tmw922","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801670537","https://openalex.org/I4210160466","https://openalex.org/I94396219"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicole Fredrich","raw_affiliation_strings":["Providence Portland Medical Center, Portland, OR;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Providence Portland Medical Center, Portland, OR;","institution_ids":["https://openalex.org/I2801670537"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029816761","display_name":"Nicole Moxon","orcid":"https://orcid.org/0000-0003-4376-9082","observed_orcids":["https://orcid.org/0000-0003-4376-9082"]},"institutions":[{"id":"https://openalex.org/I2801670537","display_name":"Providence Portland Medical Center","ror":"https://ror.org/015tmw922","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801670537","https://openalex.org/I4210160466","https://openalex.org/I94396219"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicole Moxon","raw_affiliation_strings":["Providence Cancer Center, Portland, OR;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Providence Cancer Center, Portland, OR;","institution_ids":["https://openalex.org/I2801670537"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010660964","display_name":"Sangeetha Meda Reddy","orcid":"https://orcid.org/0000-0002-8401-1481","observed_orcids":["https://orcid.org/0000-0002-8401-1481"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sangeetha M. Reddy","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006071406","display_name":"Meredith Carter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Meredith Carter","raw_affiliation_strings":["University of Texas Southwestern Medical Center, Dallas, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Southwestern Medical Center, Dallas, TX;","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069656105","display_name":"Sujata Patil","orcid":"https://orcid.org/0000-0003-1706-5321","observed_orcids":["https://orcid.org/0000-0003-1706-5321"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sujata Patil","raw_affiliation_strings":["Department of Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY;","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5039225060","display_name":"Larry Norton","orcid":"https://orcid.org/0000-0003-3701-9250","observed_orcids":["https://orcid.org/0000-0003-3701-9250"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Larry Norton","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY;","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"40","issue":"16_suppl","first_page":"TPS617","last_page":"TPS617"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.7529000043869019,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.7529000043869019,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.2378000020980835,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12626","display_name":"Cancer, Stress, Anesthesia, and Immune Response","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.7839999794960022},{"id":"https://openalex.org/keywords/perioperative-immunotherapy","display_name":"perioperative immunotherapy","score":0.7929999828338623},{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":0.9860000014305115},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":1.0},{"id":"https://openalex.org/keywords/cryoablation","display_name":"cryoablation","score":0.9769999980926514},{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.7540000081062317},{"id":"https://openalex.org/keywords/residual-disease-after-neoadjuvant-chemotherapy","display_name":"residual disease after neoadjuvant chemotherapy","score":0.746999979019165},{"id":"https://openalex.org/keywords/adjuvant-nivolumab","display_name":"adjuvant nivolumab","score":0.8059999942779541},{"id":"https://openalex.org/keywords/event-free-survival","display_name":"event-free survival","score":0.8650000095367432},{"id":"https://openalex.org/keywords/disease-free-survival","display_name":"disease-free survival","score":0.5139999985694885},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.6060000061988831},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.47699999809265137}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9312351942062378},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.7228773236274719},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.6682044267654419},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6505860686302185},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6386129856109619},{"id":"https://openalex.org/C2777628079","wikidata":"https://www.wikidata.org/wiki/Q202448","display_name":"Cryoablation","level":3,"score":0.595265805721283},{"id":"https://openalex.org/C2777511904","wikidata":"https://www.wikidata.org/wiki/Q425227","display_name":"Taxane","level":4,"score":0.5464906692504883},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5445386171340942},{"id":"https://openalex.org/C31174226","wikidata":"https://www.wikidata.org/wiki/Q64855140","display_name":"Perioperative","level":2,"score":0.5263020992279053},{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.5057947635650635},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4865040183067322},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.46764418482780457},{"id":"https://openalex.org/C2781164504","wikidata":"https://www.wikidata.org/wiki/Q1998021","display_name":"Pertuzumab","level":5,"score":0.4201648235321045},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.4166918694972992},{"id":"https://openalex.org/C2778292576","wikidata":"https://www.wikidata.org/wiki/Q6991934","display_name":"Neoadjuvant therapy","level":4,"score":0.41048765182495117},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3213670551776886},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.32020092010498047},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.25690698623657227},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.21806678175926208},{"id":"https://openalex.org/C2778902805","wikidata":"https://www.wikidata.org/wiki/Q322177","display_name":"Ablation","level":2,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.2022.40.16_suppl.tps617","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.tps617","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.tps617","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmh:oai:repository.cshl.edu:41191","doi":null,"is_oa":false,"landing_page_url":"https://repository.cshl.edu/id/eprint/41191/","pdf_url":null,"source":{"id":"https://openalex.org/S4306402288","display_name":"Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Conference or Workshop Item"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.8700000047683716,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320306239","display_name":"Conquer Cancer Foundation","ror":"https://ror.org/027327e78"},{"id":"https://openalex.org/F4320315369","display_name":"BTG","ror":"https://ror.org/05c691y47"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4376224000","https://openalex.org/W3010153683","https://openalex.org/W3173641743","https://openalex.org/W2163622510","https://openalex.org/W2197264082","https://openalex.org/W2091007248","https://openalex.org/W1969602144","https://openalex.org/W2727568273","https://openalex.org/W4281663502","https://openalex.org/W4322774012"],"abstract_inverted_index":{"TPS617":[0],"Background:":[1],"Local":[2],"tumor":[3,252],"destruction":[4],"with":[5,21,38,51,83,107,136,150,166],"cryoablation":[6],"(cryo)":[7],"induces":[8],"inflammation":[9],"and":[10,28,63,134,142,160,213,243,253,263,269],"releases":[11],"antigens":[12],"that":[13,34],"can":[14],"activate":[15],"tumor-specific":[16,25],"immune":[17,26,65],"responses.":[18,66],"Pre-clinically,":[19],"cryo":[20,37,149],"checkpoint":[22],"inhibition":[23],"augmented":[24],"responses":[27],"prevented":[29],"recurrence.":[30],"Clinically,":[31],"we":[32,72],"established":[33],"peri-operative":[35],"(peri-op)":[36],"ipilimumab":[39],"(ipi)":[40],"+/-":[41],"nivolumab":[42],"(nivo)":[43],"was":[44],"not":[45],"only":[46],"safe":[47],"in":[48,81],"patients":[49,198],"(pts)":[50],"operable,":[52],"early":[53,100],"stage":[54],"breast":[55,87,140],"cancer":[56,88],"(ESBC)":[57],"but":[58],"also":[59],"generated":[60],"robust":[61],"intra-tumoral":[62],"systemic":[64],"In":[67],"this":[68],"phase":[69],"2":[70],"study,":[71],"evaluate":[73],"the":[74,257,261],"disease":[75,124],"specific":[76],"impact":[77,259],"of":[78,99,185,260,267],"peri-op":[79],"ipi/nivo/cryo":[80,137],"women":[82],"residual":[84,122],"triple":[85],"negative":[86,115],"(TNBC)":[89],"after":[90,125],"neoadjuvant":[91],"chemotherapy":[92],"(NAC),":[93],"a":[94],"subset":[95],"at":[96,187],"high":[97],"risk":[98],"relapse.":[101],"Methods:":[102],"Eligible":[103],"pts":[104,130,179],"are":[105],"\u226518y,":[106],"ER":[108],"<":[109,112],"10%,":[110,113],"PR":[111],"HER2":[114],"(per":[116],"ASCO/CAP":[117],"definition),":[118],"\u2265":[119],"1.0":[120],"cm,":[121],"operable":[123],"taxane-based":[126],"NAC.":[127],"Approximately":[128],"80":[129],"will":[131,161,180,203,248],"be":[132,204,249],"enrolled":[133],"treated":[135],"followed":[138],"by":[139,206],"surgery":[141,159],"adjuvant":[143],"nivo.":[144],"Pts":[145],"undergo":[146],"percutaneous,":[147],"image-guided":[148],"concurrent":[151],"research":[152],"core":[153],"biopsy":[154],"7-10":[155],"days":[156,173],"prior":[157,174],"to":[158,171,175,255,264],"receive":[162,181],"ipi":[163],"(1mg/kg":[164],"IV)":[165,169],"nivo":[167,186],"(240mg":[168],"1":[170],"5":[172],"cryo.":[176],"After":[177],"surgery,":[178],"3":[182],"additional":[183],"doses":[184],"240mg":[188],"IV":[189],"Q2":[190],"weeks.":[191],"Adjuvant":[192],"capecitabine":[193],"is":[194,223],"recommended":[195],"for":[196],"all":[197],"per":[199],"local":[200],"standard-of-care.":[201],"Patients":[202],"stratified":[205],"NAC":[207,210],"platinum":[208],"administration,":[209,212],"anthracycline":[211],"clinical":[214],"nodal":[215],"status":[216],"(positive":[217],"versus":[218],"negative).":[219],"The":[220],"primary":[221],"endpoint":[222],"3-year":[224],"Event":[225],"Free":[226],"Survival":[227,234,238],"(EFS).":[228],"Secondary":[229],"endpoints":[230],"include":[231],"Invasive":[232],"Disease-Free":[233,237],"(IDFS),":[235],"Distant":[236],"(DDFS),":[239],"overall":[240],"survival":[241],"(OS)":[242],"safety.":[244],"Exploratory":[245],"correlative":[246],"studies":[247],"performed":[250],"on":[251],"serum":[254],"characterize":[256],"immunologic":[258],"intervention":[262],"explore":[265],"predictors":[266],"efficacy":[268],"toxicity.":[270],"Clinical":[271],"trial":[272],"information:":[273],"NCT03546686.":[274]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":1}],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2025-10-10T00:00:00"}